For the Inventor, By the Inventor

Enter inventor name

Wei Long

USPTO Granted Patents = 18 (Patent Applications = 13)

CIPO Patents = 12 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 21)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 17(Granted Patents)

Location History:

Beijing, CN (2014 - 2020)
Nanjing, CN (2022 - 2023)

Company Filing History:

Betta Pharmaceuticals Co., Ltd.

Beijing Betta Pharmaceuticals Co., Ltd

Beta Pharma, Inc.

4. 2 out of 2,402

Citrix Systems, Inc.

Fujian Haixi Pharmaceuticals, Inc.

Betta Pharmacueticals Co., Ltd.

7. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2023

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11580148 - Document storage and management (2023-02-14),

2. 11294930 - Resource scaling for distributed database services (2022-04-05),

3. 10577364 - Crystalline form of fused pyridine derivative's maleate and uses thereof (2020-03-03),

4. 10059688 - Protein tyrosine kinase modulators and methods of use (2018-08-28),

5. 9783524 - Protein tyrosine kinase modulators and methods of use (2017-10-10),

6. 9688687 - Polymorphic forms of icotinib phosphate and uses thereof (2017-06-27),

7. 9611272 - Polymorphic forms of icotinib and uses thereof (2017-04-04),

8. 9505774 - Polymorphic forms of icotinib maleate and uses thereof (2016-11-29),

9. 9487570 - Glucagon like peptide analogs, composition, and method of use (2016-11-08),

10. 9409900 - Compound for increasing kinase active and application thereof (2016-08-09),

11. 9359370 - Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof (2016-06-07),

12. 9242991 - Substituted fused heterocycles as c-Met tyrosine kinase inhibitors (2016-01-26),

13. 9238637 - Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof (2016-01-19),

14. 9206134 - Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof (2015-12-08),

15. 9085588 - Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof (2015-07-21),

Title: Inventor Wei Long - Revolutionizing Technology in Beijing

Introduction: Wei Long is a visionary inventor hailing from Beijing, China, who has made significant contributions to the technological landscape through his innovative creations and patents.

Latest Patents: Wei Long holds several groundbreaking patents in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Wei Long has worked with prestigious research institutions and leading tech companies, consistently pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Wei Long has collaborated with top universities and multinational corporations on various projects, fostering a culture of creativity and excellence in the pursuit of cutting-edge solutions to complex problems.

Conclusion: Wei Long's dedication to innovation and his relentless pursuit of technological advancement have solidified his reputation as a pioneering inventor in Beijing, leaving a lasting impact on the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…